Article
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
Oncogene - 10 Jul 2014
Tallet A, Nault J-C, Renier A, Hysi I, Galateau-Sallé F, Cazes A, Copin M-C, Hofman P, Andujar P, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand M-C, Jean D
Abstract excerpt
Malignant pleural mesothelioma (MPM) is a very aggressive tumor with no known curative treatment. Better knowledge of the molecular mechanisms of mesothelial carcinogenesis is required to develop new therapeutic strategies. MPM, like all cancer cells, needs to maintain telomere length to prevent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
